Allianz Asset Management Gmb H Celldex Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$20.5 - $37.33 $742,202 - $1.35 Million	-36,205 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $940,845 - $1.48 Million	26,369 Added 268.09%	36,205 $1.4 Million
Q3 2021 Nov 10, 2021	SELL	$28.95 - $55.99 $2.78 Million - $5.38 Million	-96,077 Reduced 90.71%	9,836 $531,000
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $442,054 - $754,972	21,345 Added 25.24%	105,913 $3.54 Million
Q1 2021 May 13, 2021	BUY	$16.19 - $29.91 $163,000 - $301,133	10,068 Added 13.51%	84,568 $1.74 Million
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $1.12 Million - $1.69 Million	74,500 New	74,500 $1.31 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.26B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.